Clinical Trials Logo

Meconium Aspiration clinical trials

View clinical trials related to Meconium Aspiration.

Filter by:
  • None
  • Page 1

NCT ID: NCT00371241 Completed - Sepsis Clinical Trials

Antibody Secreting Cell and Cyotokine Profiles in Neonates on ECMO

Start date: September 2006
Phase:
Study type: Observational

Infants are placed on ECMO for correction of reversible respiratory failure. Often, because a few of the reasons for respiratory failure show us similar things in the baby, it is difficult to determine exactly which is causing the biggest problem. We are now capable of measuring certain cells and proteins in these infants that may help us more accurately diagnose the exact problem. We hypothesize that infants placed on ECMO will show unique antibody-secreting cells responses and patterns of cytokine and chemokine (protein) response to illness and to the ECMO circuit. If we find unique patterns to these cells or proteins, they may be able to predict outcomes or guide treatment of these infants.

NCT ID: NCT00004500 Terminated - Meconium Aspiration Clinical Trials

Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome

Start date: March 2000
Phase: Phase 3
Study type: Interventional

OBJECTIVES: Evaluate the safety and efficacy of lucinactant administered by bronchoalveolar lavage (BAL) in the treatment of meconium aspiration syndrome (MAS) in newborn infants.